A study to assess the period effect (and the effect of food) on processing by the body of RO7268489 following single oral-dose administration in healthy participants

Phase 1

• Conditions: Healthy participants; Not Applicable

• Registration Number: ISRCTN74851494
• Lead Sponsor: F. Hoffmann-La Roche

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-07-10
• Last Update Posted: 19 December 2023
• Study Completion: 2024-03-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

1. Male or female participants who are overtly healthy (defined by absence of evidence of any active or chronic disease)
2. Body mass index (BMI) within the range of 18 to 32 kilograms per square meter (kg/m2) (inclusive)

Exclusion Criteria

1. History of malignancy in the past 5 years
2. History or evidence of any medical condition potentially altering the absorption, metabolism, or elimination of drugs.
3. Vaccination within 6 weeks prior to Day 1 including influenza and/or SARS-CoV-2/ COVID-19 vaccination.

Study & Design

• Study Type: Interventional
• Study Design: Not specified